Copyright
©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1798-1813
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1798
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1798
Figure 3 The inhibition of Sirtuin1 induced activation of hypoxia inducible factor-1α and subsequently increased hypoxia-induced reactive oxygen species production.
A: Western blotting was performed to measure the levels of Sirtuin1 (Sirt1) and hypoxia inducible factor (HIF)-1α in L02 cells; B: Reactive oxygen species (ROS) productions were detected by dihydroethidium (DHE) staining. Representative images of the DHE staining in different groups; C: ROS productions were evaluated by quantification of mean fluorescence intensity in DHE staining; D: Western blotting was performed to measure the levels of Sirt1 and HIF-1α in L02 cells; E and F: ROS productions were detected by DHE staining. Data shown are means ± standard deviations (SDs) of three separate experiments. aP < 0.05 vs Control group; bP < 0.05 vs Lipopolysaccharide (LPS)-treated group; cP < 0.05 vs LPS + Hypoxia-treated group; one-way analysis of variance with Bonferroni's post hoc test; the error bars indicate the SDs.
- Citation: Cao P, Chen Q, Shi CX, Wang LW, Gong ZJ. Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α. World J Gastroenterol 2022; 28(17): 1798-1813
- URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1798.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1798